当前位置: X-MOL 学术Cancer Discov. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The T-cell Receptor β-Chain Is an Immunotherapy Target for Lymphomas
Cancer Discovery ( IF 28.2 ) Pub Date : 2018-01-01 , DOI: 10.1158/2159-8290.cd-rw2017-220
American Association for Cancer Research

Targeting the TRBC gene expressed by T-cell malignancies mitigates severe immunosuppression.



中文翻译:

T细胞受体β链是淋巴瘤的免疫治疗目标。

靶向由T细胞恶性肿瘤表达的TRBC基因可减轻严重的免疫抑制。

更新日期:2018-01-08
down
wechat
bug